137 related articles for article (PubMed ID: 33168223)
1. A scalable device-less biomaterial approach for subcutaneous islet transplantation.
Vlahos AE; Talior-Volodarsky I; Kinney SM; Sefton MV
Biomaterials; 2021 Feb; 269():120499. PubMed ID: 33168223
[TBL] [Abstract][Full Text] [Related]
2. Methacrylic acid copolymer coating of polypropylene mesh chamber improves subcutaneous islet engraftment.
Coindre VF; Kinney SM; Sefton MV
Biomaterials; 2020 Nov; 259():120324. PubMed ID: 32858417
[TBL] [Abstract][Full Text] [Related]
3. Degradable methacrylic acid-based synthetic hydrogel for subcutaneous islet transplantation.
Kinney SM; Ortaleza K; Vlahos AE; Sefton MV
Biomaterials; 2022 Feb; 281():121342. PubMed ID: 34995903
[TBL] [Abstract][Full Text] [Related]
4. Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets.
Vlahos AE; Cober N; Sefton MV
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):9337-9342. PubMed ID: 28814629
[TBL] [Abstract][Full Text] [Related]
5. Endothelialized collagen based pseudo-islets enables tuneable subcutaneous diabetes therapy.
Vlahos AE; Kinney SM; Kingston BR; Keshavjee S; Won SY; Martyts A; Chan WCW; Sefton MV
Biomaterials; 2020 Feb; 232():119710. PubMed ID: 31901691
[TBL] [Abstract][Full Text] [Related]
6. Engineered islet cell clusters transplanted into subcutaneous space are superior to pancreatic islets in diabetes.
Pathak S; Regmi S; Gupta B; Pham TT; Yong CS; Kim JO; Yook S; Kim JR; Park MH; Bae YK; Jeong JH
FASEB J; 2017 Nov; 31(11):5111-5121. PubMed ID: 28754712
[TBL] [Abstract][Full Text] [Related]
7. Injectable and inherently vascularizing semi-interpenetrating polymer network for delivering cells to the subcutaneous space.
Mahou R; Zhang DKY; Vlahos AE; Sefton MV
Biomaterials; 2017 Jul; 131():27-35. PubMed ID: 28371625
[TBL] [Abstract][Full Text] [Related]
8. Insulin-induced normoglycemia reduces islet number needed to achieve normoglycemia after allogeneic islet transplantation in diabetic mice.
Ferrer-Garcia JC; Merino-Torres JF; Pérez Bermejo G; Herrera-Vela C; Ponce-Marco JL; Piñon-Selles F
Cell Transplant; 2003; 12(8):849-57. PubMed ID: 14763504
[TBL] [Abstract][Full Text] [Related]
9. Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device.
Pepper AR; Pawlick R; Gala-Lopez B; MacGillivary A; Mazzuca DM; White DJ; Toleikis PM; Shapiro AM
Transplantation; 2015 Nov; 99(11):2294-300. PubMed ID: 26308506
[TBL] [Abstract][Full Text] [Related]
10. Modified subcutaneous tissue with neovascularization is useful as the site for pancreatic islet transplantation.
Kawakami Y; Iwata H; Gu Y; Miyamoto M; Murakami Y; Yamasaki T; Cui W; Ikada Y; Imamura M; Inoue K
Cell Transplant; 2000; 9(5):729-32. PubMed ID: 11144974
[TBL] [Abstract][Full Text] [Related]
11. A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver.
Yasunami Y; Nakafusa Y; Nitta N; Nakamura M; Goto M; Ono J; Taniguchi M
Transplantation; 2018 Jun; 102(6):945-952. PubMed ID: 29521877
[TBL] [Abstract][Full Text] [Related]
12. Development of an ectopic site for islet transplantation, using biodegradable scaffolds.
Dufour JM; Rajotte RV; Zimmerman M; Rezania A; Kin T; Dixon DE; Korbutt GS
Tissue Eng; 2005; 11(9-10):1323-31. PubMed ID: 16259588
[TBL] [Abstract][Full Text] [Related]
13. Outcome of subcutaneous islet transplantation improved by polymer device.
Juang JH; Bonner-Weir S; Ogawa Y; Vacanti JP; Weir GC
Transplantation; 1996 Jun; 61(11):1557-61. PubMed ID: 8669096
[TBL] [Abstract][Full Text] [Related]
14. Effect of Cell Density of a Methacrylic Acid-Based Hydrogel Implant on Embedded Islet Function and Viability.
Ortaleza K; Sefton MV
Tissue Eng Part A; 2024 Mar; 30(5-6):204-213. PubMed ID: 37962272
[TBL] [Abstract][Full Text] [Related]
15. Vascularization of PLGA-based bio-artificial beds by hypoxia-preconditioned mesenchymal stem cells for subcutaneous xenogeneic islet transplantation.
Kim JS; Jung Y; Kim SH; Shin JS; Kim SH; Park CG
Xenotransplantation; 2019 Jan; 26(1):e12441. PubMed ID: 30054954
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of vascularization of a subcutaneous scaffold applicable for pancreatic islet-transplantation enhances immediate post-transplant islet graft function but not long-term normoglycemia.
Smink AM; Li S; Swart DH; Hertsig DT; de Haan BJ; Kamps JAAM; Schwab L; van Apeldoorn AA; de Koning E; Faas MM; Lakey JRT; de Vos P
J Biomed Mater Res A; 2017 Sep; 105(9):2533-2542. PubMed ID: 28470672
[TBL] [Abstract][Full Text] [Related]
17. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization.
Zhang N; Richter A; Suriawinata J; Harbaran S; Altomonte J; Cong L; Zhang H; Song K; Meseck M; Bromberg J; Dong H
Diabetes; 2004 Apr; 53(4):963-70. PubMed ID: 15047611
[TBL] [Abstract][Full Text] [Related]
18. Novel in vivo murine model to study islet potency: engraftment and function.
Bharat A; Benshoff N; Olack B; Ramachandran S; Desai NM; Mohanakumar T
Transplantation; 2005 Jun; 79(11):1627-30. PubMed ID: 15940055
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets.
Lacy PE; Hegre OD; Gerasimidi-Vazeou A; Gentile FT; Dionne KE
Science; 1991 Dec; 254(5039):1782-4. PubMed ID: 1763328
[TBL] [Abstract][Full Text] [Related]
20. Local, Controlled Release In Vivo of Vascular Endothelial Growth Factor Within a Subcutaneous Scaffolded Islet Implant Reduces Early Islet Necrosis and Improves Performance of the Graft.
Gebe JA; Preisinger A; Gooden MD; D'Amico LA; Vernon RB
Cell Transplant; 2018 Mar; 27(3):531-541. PubMed ID: 29756517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
